APGI Researchers Recognised
Dr Marina Pajic presented her work to develop personalised medicines for pancreatic cancer patients at the European Association for Cancer Research's Biennial Congress in Barcelona earlier this year. Dr Pajic was awarded the Proffered Abstract Award for her distinguished work. As part of the APGI, Dr Pajic is working with preclinical models to investigate new agents proposed for personalised pancreatic cancer treatment. This research has lead to the IMPACT trial, a new project looking at individualising treatment of patients with metastatic pancreatic cancer. To find out more about her research see this with .
Dr Andreia Pinho is one of three young scientists to be awarded the 2012 Young Garvan Fellow by the Garvan Institute for her outstanding work in pancreatic cancer research. The Young Garvan is a group of Sydney professionals committed to progressing awareness of, and funding for, medical research. Dr Pinho is a researcher with the APGI and this award will help further her work into the underlying development of pancreatic cancer cells.